Filters

Documents

Showing 25 of 893 items meeting your criteria.
Items per page
 TypeCategorySupplier 
 
Cellpeutics is a specialised antibody development division of T-Cure Bioscience focused on developing research antibodies for major allergens, difficult proteins, and underserved research targets.
Documents
Antibodies
Cellpeutics
CGT Global are a leading provider of human peripheral blood, bone marrow and cord blood products, with U.S. FDA registration and 4 independently owned and operated sites across the United States to collect blood, cells, and tissue from patients and donors. Both CGTs fresh and cryopreserved leukopaks work well for CAR T, but the difference is what they optimise for. Here is a guide to help you choose the right one for you.
Documents
Human Blood Products
CGT Global
Supporting reliable results and scalable innovation
Documents
Proteins
LeadGene Biomedical
Unlock protein purity with precision
Documents
Proteins
LeadGene Biomedical
Elevate your Nipah virus research with Leadgenes top-tier proteins and anti-Nipah virus antibodies
Documents
Virology
LeadGene Biomedical
Unleash the power of fast, efficient mRNA transfection
Documents
Transfection
LeadGene Biomedical
Your solution to residue-free biotin labeling
Documents
Kits
LeadGene Biomedical
High performance labeling
Documents
Kits
LeadGene Biomedical
Explore Leadgenes innovative range of enzyme products and ELISA Kits tailored for glycan removal, protein modification and precise quality control.
Documents
Enzymes
LeadGene Biomedical
Elabscience provides a comprehensive portfolio of rigorously validated metabolic assay kits, engineered to deliver high analytical sensitivity, reproducibility, and compatibility across diverse biological matrices and experimental platforms.
Documents
Metabolism
Elabscience
Western Blot (WB) remains the gold standard for protein identification and molecular weight determination, harnessing highly specific antigen-antibody interactions to deliver sensitive and reliable protein detection across diverse research applications. Elabscience provides a range of products for Western Blot workflows.
Documents
Methods
Elabscience
Elabscience® provides comprehensive, workflow-integrated solutions supporting CAR-T research from foundational exploration through preclinical development.
Documents
Immunology
Elabscience
At Procell, we are committed to providing high-quality, reliable cell culture solutions designed to support stable cell growth and optimal performance across a broad spectrum of cell types. Backed by extensive validation and cutting-edge research, our products ensure consistent results and minimal variability. From primary cell isolation to advanced functional assays, our comprehensive range of products are tailored to meet the needs of modern cell culture and research.
Documents
Catalogue
Procell system
Procell leverages an internally validated cell bank, optimised culture systems, differentiation protocols, and exosome isolation protocols to address key research challenges and to enable stable expansion and versatile applications of MSCs.
Documents
Cell Culture
Procell system
Elabscience provides a range of products for the study of oxidative stress.
Documents
Metabolism
Elabscience
Elabscience provides a range of products for the study of energy metabolism.
Documents
Metabolism
Elabscience
Elabscience provides a range of research tools for application in Diabetes studies.
Documents
Metabolism
Elabscience
Abnova provides integrated Antibody LNP Conjugation Services to support research and preclinical development programs. Their capabilities include the use of customer-provided or Abnova-generated antibodies, LNP formulation development, and conjugation strategy optimisation. Leveraging expertise in antibodies, RNA technologies, and nanoparticle development, we deliver customised solutions tailored to diverse research and therapeutic applications.
Documents
Service
Abnova Corporation
Cancer remains one of the most active areas of biomedical research, driving continuous advances in immunotherapy, targeted therapeutics, biomarker discovery, and precision medicine. To support cancer research from basic biology to translational studies, Abnova offers a comprehensive portfolio of antibodies, recombinant proteins, and ELISA kits covering key oncology pathways and targets. This catalog highlights antibodies, recombinant proteins, and ELISA kits supporting research in Immuno-Oncology, Cell Therapy, Targeted Therapy, Biomarkers, DNA Repair, Tumor Microenvironment, Cell Signaling, Cancer Stem Cells, Tumor Suppressors, Cell Death, Hematologic Oncology, and Cancer Metabolism. Our products are designed to support studies in tumor biology, immune regulation, therapeutic target validation, biomarker development, and drug discovery.
Documents
Cancer
Abnova Corporation
Abnova offers a comprehensive portfolio of proteins, antibodies, and ELISA kits to support infectious disease research across a wide range of pathogens, including viruses, bacteria, protozoans, parasites, and fungi. Their products are designed to enable reliable detection, characterisation, and quantification of disease-related targets, supporting applications from basic research to translational studies. With high specificity, sensitivity, and consistent performance, our reagents facilitate efficient assay development and reproducible results. Explore our curated selection to advance your research in pathogen biology, host–pathogen interactions, and diagnostic development.
Documents
Immunology
Abnova Corporation
Next-generation miRNA inhibition with enhanced stability and performance
Documents
RNA
Abnova Corporation
Biologics development requires accurate quantification and reliable immunogenicity assessment to ensure safety and efficacy. Abnova provides Biosimilar and Immunogenicity Research Tools to support key workflows from drug measurement to immune response evaluation. Abnovas portfolio includes biosimilar antibodies and ELISA kits for comparative and PK studies, as well as ADA reagents and ELISA kits for immunogenicity assessment. These solutions provide high sensitivity and reproducibility, enabling efficient and consistent research outcomes.
Documents
Immunology
Abnova Corporation
The acquisition and transport of fresh human tissues impose stringent logistical and biological constraints that directly impact downstream model fidelity. High-specification samples remain scarce, must be accepted within hours of resection, and exhibit rapid viability and phenotypic decay when held in conventional liquid media, leaving a narrow window for QC, allocation, and delivery. These constraints frequently lead to sample loss, reduced cellular yield, and compromised microenvironmental integrity before processing can begin. TissueReady™ PLUS addresses these limitations by extending ex vivo stability from <24 hours to up to 5 days, preserving cell viability, tumour content, and histological and molecular features, thereby enabling more flexible coordination, reduced wastage, and improved reliability of primary tissue-derived model generation.
Documents
Sample Preservation
Atelerix
This whitepaper documents how Atelerixs hydrogel technology, CytoStor, can enable hypothermic viral and vaccine stabilisation for cryo-free logistics, providing case examples specifically of SARSCoV-2, Adenovirus, Lentivirus, Lentiviral Vectors, and LNP-mRNA viral vectors.
Documents
Sample Preservation
Atelerix
TissueReady PLUS offers a simple solution that preserves the viability and quality of fresh tissue at ambient temperatures, increasing shelf life, enabling shipment, enhancing the flexibility of workflows and improving the quality of screening and model generation from these tissues.
Documents
Sample Preservation
Atelerix